Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David D. Meek files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Matthew C. Kapusta - $12.86M in QURE purchases and sales in the last 12 months
- Lynx1 Capital Management LP - $3.50M in CGEM purchases and sales in the last 12 months
- Walid Abi-Saab - $2.61M in QURE purchases and sales in the last 12 months
- Jack Kaye - $2.52M in QURE purchases and sales in the last 12 months
- Jennifer Michaelson - $1.62M in CGEM purchases and sales in the last 12 months
- Robert Gut - $1.13M in QURE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David D. Meek?
David D. Meek is a corporate insider of Cullinan Therapeutics, Inc. (CGEM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did David D. Meek last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 2 filings going back to 2026.
Has David D. Meek been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($54K) across all tracked filings.
